This week’s newsletter covers the fascinating world of plant-based self-medication in animals, new research on CBD, THC, and the endocannabinoid system, and the latest findings on ketamine and psychedelic-assisted therapies.

Noteworthy Read

Animals Self-Medicate with Plants (The Conversation)

Animals have been observed using plants to self-medicate for millennia, a behavior that humans have emulated for medicinal purposes, highlighting the natural origins of many therapies.

Read more

View more in Endocannabinoid System

More Noteworthy Reading

MDMA-Assisted Therapy and the Inner Healing Intelligence (Chemical Poetics)

This article explores how MDMA-assisted therapy fosters communication with an individual’s “inner healing intelligence,” offering unique insights into its therapeutic potential.

Read more

View more in Psychedelics

Cannabis Restrictions Persist on Facebook Despite Policy Updates (Marijuana Moment)

Despite updates to Facebook’s policies promoting free expression, restrictions on cannabis-related accounts persist, limiting the industry’s ability to advertise and engage on the platform.

Read more

View more in CBD

Cannabis Museum Sheds Light on Forgotten History (Athens News)

A new cannabis museum highlights the overlooked history of cannabis in the U.S., from its early medicinal use to the modern legalization movement, offering a rich cultural perspective commonly omitted from mainstream discussions of the plant.

Read more

View more in CBD

Research Round-Up

Ketamine’s Impact on the Endocannabinoid System (PubMed)

Research shows that ketamine impacts the endocannabinoid system, suggesting it plays a role in the drug’s rapid antidepressant effects.

Read more

View more in Endocannabinoid System

Cannabis Smoke and Oral THC Improve Memory in Older Animals (PubMed)

A study finds that cannabis smoke and oral THC improve memory performance in older animals, highlighting age-specific cognitive benefits.

Read more

View more in THC

The Role of Awe in Ketamine’s Antidepressant Effects (PMC)

A study explores how the sense of awe experienced during ketamine treatment contributes to its antidepressant effects, offering insights into its therapeutic mechanisms.

Read more

View more in Psychedelics

Cannabinoids and the Gut Microbiome (PubMed)

Emerging research investigates the interaction between cannabinoids and the gut microbiome, revealing potential therapeutic implications for immune and digestive health.

Read more

View more in Endocannabinoid System

Phytocannabinoid-Based Formulations for Skin Health (PubMed)

This study examines the benefits of phytocannabinoid-based formulations for skin health, including anti-inflammatory and antioxidant effects, showcasing their potential in dermatological products.

Read more

View more in CBD

A heartfelt thank you to all of the CBD brands whose generous support empowers Project CBD to keep shining a light on the most important plant medicine research and journalism from around the world.

More from this category